AmbioPharm currently manufactures Peptide APi’s for both pharmaceutical and biotechnology companies in multiple clinical studies:
Ophthalmology
Osteoporosis
Allergy / asthma
Analgesia
Epilepsy
Alopecia
Gynecology
Vaccines
CNS disease
Inflammation
Antiviral
CV disease
Antibacterial
Growth impairment
GI disease
Diabetes
Obesity
Cancer
Hemopoiesis
Arthritis
AmbioPharm is also partnering with generic drug companies to develop many generic peptide drugs:
Bivalirudin
Cosyntropin
Eptifibatide
Exenatide
GLP-1( 7-37 )
Glucagon ( 1-29 )
Glatiramer
Leuprolide Acetate
Nesiritide
Octreotide Acetate
Pramlintide
Thymosin alpha 1
Triptorelin Acetate
Triptorelin Pamoate
Disclaimer:
a) Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyers risk.
b) Products currently covered by valid U.S patents. are offered for R & D use in accordance with 35 USC 271( e) + A13( 1)
c) Product list is covered under “ Bolar Provision” and only non commercial samples for R & D are available.
